Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001013762-25-003343
Filing Date
2025-03-27
Accepted
2025-03-27 16:01:45
Documents
87
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0232429-10k_60degrees.htm   iXBRL 10-K 1991958
2 INSIDER TRADING POLICY ea023242901ex19-1_60degrees.htm EX-19.1 90195
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea023242901ex23-1_60degrees.htm EX-23.1 2287
4 CERTIFICATION ea023242901ex31-1_60degrees.htm EX-31.1 9949
5 CERTIFICATION ea023242901ex31-2_60degrees.htm EX-31.2 10035
6 CERTIFICATION ea023242901ex32-1_60degrees.htm EX-32.1 3783
7 CERTIFICATION ea023242901ex32-2_60degrees.htm EX-32.2 3827
8 GRAPHIC image_001.jpg GRAPHIC 315221
  Complete submission text file 0001013762-25-003343.txt   11297703

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE sxtp-20241231.xsd EX-101.SCH 84596
10 XBRL CALCULATION FILE sxtp-20241231_cal.xml EX-101.CAL 77306
11 XBRL DEFINITION FILE sxtp-20241231_def.xml EX-101.DEF 480618
12 XBRL LABEL FILE sxtp-20241231_lab.xml EX-101.LAB 897274
13 XBRL PRESENTATION FILE sxtp-20241231_pre.xml EX-101.PRE 503348
89 EXTRACTED XBRL INSTANCE DOCUMENT ea0232429-10k_60degrees_htm.xml XML 1067757
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41719 | Film No.: 25779194
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)